永安药业：拟2700万元收购控股子公司少数股东股权

Core Viewpoint - The company plans to acquire a 49.20% stake in its subsidiary Hubei Ling'an Technology Co., Ltd. from minority shareholders for 27 million yuan, aiming to strengthen control and accelerate market positioning in its business areas [1] Group 1 - The acquisition will be funded by the company's own funds, ensuring that normal production and operations are not affected [1] - Following the completion of the transaction, Ling'an Technology will become a wholly-owned subsidiary of the company [1] - This move aligns with the company's overall strategic planning [1]